CNSide Diagnostics, LLC is a company dedicated to developing and commercializing proprietary clinical diagnostic laboratory assays. The first-in-class CNSide® assay is performed in a CLIA-registered, CAP-accredited facility in Houston, Texas. CNSide® is a highly sensitive, cerebrospinal fluid-based, laboratory developed test (LDT) for patients with Leptomeningeal Metastases (LM) from carcinomas and melanomas. By enabling quantitative analysis and molecular characterization of tumor cells, we provide powerful insights to healthcare providers that guide patient care and treatment decisions.
| Website | https://cnside-dx.com/ |
| Employees | 21 (14 on RocketReach) |
| Founded | 2024 |
| Industry | Medical and Diagnostic Laboratories |
Looking for a particular CNSide Diagnostics employee's phone or email?
CNSide Diagnostics Questions
Russell Bradley is the President and General Manager of CNSide Diagnostics.
14 people are employed at CNSide Diagnostics.
Top CNSide Diagnostics Employees
-
25+
-
Colby Suire
VP of Research and Development at CNSide Diagnostics
Houston, TX, US45+ -
Daniel Poche
Controller at CNSide Diagnostics
Houston, TX, US3 -
12
-
Elaine Luckey
Director of Quality at CNSide Diagnostics
United States15+ -
Nikki Taylor
Precision Diagnostics Account Executive at CNSide Diagnostics
Oklahoma City, OK, US11 -
Kelly Ondrasek
Medical Science Liaison at CNSide Diagnostics
Austin, TX, US11 -
Marcel Reevey
Manufacturing Manager at CNSide Diagnostics
Leander, TX, US23
